AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA STILL A VALID TREATMENT OPTION, OR IS THE GAME OVER ?
<p>Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab (FCR) has been established as the current standard of care for young and fit patients with chronic lymphocytic leukemia (CLL). In the early nineties of the last century, long before the advent of fludarabine or ant...
Saved in:
| Main Authors: | Fabienne McClanahan, Peter Dreger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2012-01-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/article/view/11074 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Refractory chronic lymphocytic leukemia with concomitant extramedullary multiple myeloma with lymph node involvement
by: Piotr Jachimowski, et al.
Published: (2024-12-01) -
miR-155 and miR-223 as markers of biological and clinical features of chronic lymphocytic leukemia
by: M. L. Perepechaeva, et al.
Published: (2024-03-01) -
Unveiling the Burden of Leukemia in Eritrea (2010–2020): Chronic Leukemia Stability, Rising ALL Incidence, and the Enigma of CML in a Low‐Resource Setting
by: Daniel Mebrahtu Abraha, et al.
Published: (2025-06-01) -
Is Salvage Autologous Stem Cell Transplantation Still a Viable Treatment Option in Relapsed Myeloma Patients?
by: Luka Čemažar, et al.
Published: (2025-05-01) -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
by: Pavankumar Tandra, et al.
Published: (2013-11-01)